SCHEMBL9901675

SCHEMBL9901675

[SiH3][SiH][SiH3]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4520004 0.75
SCHEMBL6519556 0.67
SCHEMBL6519554 0.67
SCHEMBL1974170 0.61
SCHEMBL6695874 0.61
SCHEMBL20267772 0.61
SCHEMBL64669 0.61
SCHEMBL17229150 0.61
SCHEMBL28588 0.58
Hydrogen Sulfide SCHEMBL5318198 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108610482-B Dendronized organosilicon polymer containing silicon-oxygen six-membered ring, crosslinked body and preparation method 北京航空航天大学 2021-09-21 CN claimed
CN-116265033-A Long-acting anticoagulation coating and plasma preparation method and application thereof 中国科学院深圳先进技术研究院 2023-06-20 CN disclosed
CN-108610482-B Dendronized organosilicon polymer containing silicon-oxygen six-membered ring, crosslinked body and preparation method 北京航空航天大学 2021-09-21 CN disclosed
EP-3507104-A1 PRODUCTION OF CIS-1,4-POLYDIENES WITH MULTIPLE SILANE FUNCTIONAL GROUPS PREPARED BYIN-SITU Bridgestone Corporation (JP) 2019-07-10 EP disclosed
WO-2018045291-A1 PRODUCTION OF CIS-1,4-POLYDIENES WITH MULTIPLE SILANE FUNCTIONAL GROUPS PREPARED BY IN-SITU HYDROSILYLATION OF POLYMER CEMENT BRIDGESTONE CORPORATION (JP) 2018-03-08 WO disclosed
CN-106573962-A Novel glycan conjugates and uses thereof 中央研究院 2017-04-19 CN disclosed
EP-2797969-A1 BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES Bridgestone Corporation (JP) 2014-11-05 EP disclosed
EP-2751142-A1 POLYMERS FUNCTIONALIZED WITH LACTONES OR THIOLACTONES CONTAINING A PROTECTED AMINO GROUP Bridgestone Corporation (JP) 2014-07-09 EP disclosed
EP-2649102-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP Bridgestone Corporation (JP) 2013-10-16 EP disclosed
WO-2013101861-A1 BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (JP) 2013-07-04 WO disclosed
CN-100356916-C Pharmaceutical compositions LILLY CO ELI (US) 2007-12-26 CN disclosed
CN-1812995-A Industrially scalable nucleoside synthesis IDENIX CAYMAN LTD (KY) 2006-08-02 CN disclosed
CN-1713909-A Aminoindazole derivatives and their use as kinase inhibitors AVENTIS PHARMA SA (FR) 2005-12-28 CN disclosed
CN-1093536-C 5-lipoxygenase inhibitors PFIZER (US) 2002-10-30 CN disclosed
CN-1349541-A L-ribose-LNA analogs EXIQON AS (DK) 2002-05-15 CN disclosed
CN-1059210-C Process for preparing 6-heterocyclic-4-amino-1, 3,4, 5-tetrahydrobenz [ cd ] indoles and their pharmaceutically acceptable acid addition salts LILLY CO ELI (US) 2000-12-06 CN disclosed
CN-1268352-A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole LILLY CO ELI (US) 2000-10-04 CN disclosed
CN-1233957-A Pharmaceutical compositions LILLY CO ELI (US) 1999-11-03 CN disclosed
CN-1169722-A 5-lipoxygenase inhibitors PFIZER (US) 1998-01-07 CN disclosed
CN-1066072-A 6-heterocyclic-4-amino-1, 3, 4, 5-tetrahydrobenzo [ cd ] indoles LILLY CO ELI (US) 1992-11-11 CN disclosed